Transaction · 0001601830-26-000007

Borgeson Blake

Borgeson Blake, DIR, reported an open-market or private sale at RECURSION PHARMACEUTICALS, INC. involving 220000.000000 shares for an estimated $924000.00. Reported holdings after the transaction were 6429863.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
RXRXRECURSION PHARMACEUTICALS, INC.
Filing timeFeb 06
Trade dateFeb 03, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.98
Pre-filing
1mo ago +5.5%1w ago +15.3%1d ago +5.0%
Returns since
7d -12.3%30d -13.1%90d -17.8%180d -20.4%1y -16.1%

RXRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RXRX since 2026-02-06Filed 210 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001601830-26-000007
Class A Common Stock
Transaction date
Feb 03, 2026
Filed Feb 06, 2026, 10:53 PM · 3d delay
Shares
220k sh
$420 per share
Estimated value
-$92.4M
Computed from shares × price
Holdings after
6.42M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.

Original filing · 0001601830-26-000007
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RXRX